Nuklearmedizin - NuclearMedicine

LinksSchließen

Referenz

Grubmuller B, Senn D, Kramer G. et al.
Response assessment using (68)Ga-PSMA ligand PET in patients undergoing (177)Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer.

Eur J Nucl Med Mol Imaging 2019;
46 (05) 1063-1072
DOI: 10.1007/s00259-018-4236-4. (PMID: 30569186)

Bibliographische Angaben herunterladen

Aufrufen in: